82 related articles for article (PubMed ID: 33919154)
1. The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.
Hedl M; Zheng S; Abraham C
J Immunol; 2014 Jun; 192(12):5924-32. PubMed ID: 24842757
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils impaired by anti-galectin-3 antibodies elicit inflammation of endothelial cells to aggregate the development of lupus cutaneous vasculitis.
Hu FQ; Lu SY; Shi ZR; Lai YX; Ren YL; Wu J; Tan GZ; Zeng K; Wang L
Clin Exp Rheumatol; 2024 May; ():. PubMed ID: 38757282
[TBL] [Abstract][Full Text] [Related]
3. Exploring the ROS reduction strategies in chronic lupus management.
Kannan KP; Girija A S S
Front Immunol; 2024; 15():1346656. PubMed ID: 38444846
[No Abstract] [Full Text] [Related]
4. Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus.
Furie RA; Bruce IN; Dörner T; Leon MG; Leszczyński P; Urowitz M; Haier B; Jimenez T; Brittain C; Liu J; Barbey C; Stach C
Rheumatology (Oxford); 2021 Nov; 60(11):5397-5407. PubMed ID: 33956056
[TBL] [Abstract][Full Text] [Related]
5. Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE.
Niewold TB; Meves A; Lehman JS; Popovic-Silwerfeldt K; Häyry A; Söderlund-Matell T; Charlesworth CM; Madden B; Lundberg IE; Wahren-Herlenius M; Svenungsson E; Oke V
Arthritis Res Ther; 2021 Apr; 23(1):132. PubMed ID: 33931094
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 exacerbates symptoms in an MRL/MpJ-Faslpr mouse model of systemic lupus erythematosus.
Li L; Sun X; Wu S; Yuan X; Liu B; Zhou X
Exp Ther Med; 2021 Jun; 21(6):627. PubMed ID: 33936283
[TBL] [Abstract][Full Text] [Related]
7. SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy.
Larosa M; Costedoat-Chalumeau N; Guettrot-Imbert G; Le Guern V; Morel N; Jesus D; Iaccarino L; Inês L; Doria A
Front Pharmacol; 2021; 12():660123. PubMed ID: 33935783
[No Abstract] [Full Text] [Related]
8. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus.
de la Visitación N; Robles-Vera I; Toral M; Gómez-Guzmán M; Sánchez M; Moleón J; González-Correa C; Martín-Morales N; O'Valle F; Jiménez R; Romero M; Duarte J
Br J Pharmacol; 2021 Sep; 178(18):3708-3729. PubMed ID: 33931880
[TBL] [Abstract][Full Text] [Related]
9. Urinary Peptides as Potential Non-Invasive Biomarkers for Lupus Nephritis: Results of the Peptidu-LUP Study.
Tailliar M; Schanstra JP; Dierckx T; Breuil B; Hanouna G; Charles N; Bascands JL; Dussol B; Vazi A; Chiche L; Siwy J; Faguer S; Daniel L; Daugas E; Jourde-Chiche N; On Behalf Of The Groupe Coopératif Sur le Lupus Rénal Gclr
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920017
[No Abstract] [Full Text] [Related]
10. Biological and clinical roles of IL-18 in inflammatory diseases.
Landy E; Carol H; Ring A; Canna S
Nat Rev Rheumatol; 2024 Jan; 20(1):33-47. PubMed ID: 38081945
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus: latest insight into etiopathogenesis.
Akhil A; Bansal R; Anupam K; Tandon A; Bhatnagar A
Rheumatol Int; 2023 Aug; 43(8):1381-1393. PubMed ID: 37226016
[TBL] [Abstract][Full Text] [Related]
12. Pangenome obtained by long-read sequencing of 11 genomes reveal hidden functional structural variants in pigs.
Jiang YF; Wang S; Wang CL; Xu RH; Wang WW; Jiang Y; Wang MS; Jiang L; Dai LH; Wang JR; Chu XH; Zeng YQ; Fang LZ; Wu DD; Zhang Q; Ding XD
iScience; 2023 Mar; 26(3):106119. PubMed ID: 36852268
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
14. Differential reactive oxygen species production of neutrophils and their oxidative damage in patients with active and inactive systemic lupus erythematosus.
Elloumi N; Ben Mansour R; Marzouk S; Mseddi M; Fakhfakh R; Gargouri B; Masmoudi H; Lassoued S
Immunol Lett; 2017 Apr; 184():1-6. PubMed ID: 28163154
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
16. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
Tumurkhuu G; Montano E; Jefferies C
Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Wirestam L; Arve S; Linge P; Bengtsson AA
Front Immunol; 2019; 10():2734. PubMed ID: 31824510
[TBL] [Abstract][Full Text] [Related]
18. Elevated Interleukin-18 Receptor Accessory Protein Mediates Enhancement in Reactive Oxygen Species Production in Neutrophils of Systemic Lupus Erythematosus Patients.
Ma J; Lam IKY; Lau CS; Chan VSF
Cells; 2021 Apr; 10(5):. PubMed ID: 33919154
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
